- £286.19m
- £270.09m
- £48.70m
Full Year Trading Update
Block Listing Application
Director/PDMR Shareholding
Holding(s) in Company
Block Listing Application
Holding(s) in Company
Holding(s) in Company
INTERIM RESULTS
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
PDMR/PCA Shareholding
Brief: Niox Group Reports 20% Revenue Growth To £25.2M In H1
Trading Update
Director/PDMR Shareholding
Holding(s) in Company
Holding(s) in Company
Brief: Astrazeneca Holds 15.86% Stake In Niox Group As Of May 20, Says Filing
Holding(s) in Company